Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study-Reference-Cited by-同舟云学术

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

Published:2012 Issue:4 Volume:96 Page:294-300
ISSN:1423-0194
Container-title:Neuroendocrinology
language:en
Short-container-title:Neuroendocrinology

Author:

Maire Frédérique,Lombard-Bohas Catherine,OToole Dermot,Vullierme Marie-Pierre,Rebours Vinciane,Couvelard Anne,Pelletier Anne Laure,Zappa Magaly,Pilleul Frank,Hentic Olivia,Hammel Pascal,Ruszniewski Philippe

Publisher

S. Karger AG

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Reference31 articles.

1. Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours

2. Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas

3. Aggressive surgery for metastatic liver neuroendocrine tumors

4. Surgical treatment of neuroendocrine metastases to the liver

5. Two-step Surgery for Synchronous Bilobar Liver Metastases From Digestive Endocrine Tumors: A Safe Approach for Radical Resection

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Surgical treatment and literature review of a recurrent case of glucagonoma;Frontiers in Oncology;2024-08-26

2. Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?;Seminars in Interventional Radiology;2024-02

3. Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT;Diagnostic and Interventional Imaging;2024-01

4. Liver-Directed Therapies in Neuroendocrine Tumors;Neuroendocrine Tumours;2024

5. Non-Functioning Pancreatic Neuroendocrine Tumors;Neuroendocrine Tumours;2024